385 A first-in-human study of lemzoparlimab, a differentiated anti-CD47 antibody, in subjects with relapsed/refractory malignancy: initial monotherapy results

oleh: Ajay Gopal, Mahesh Seetharam, Alex Adjei, Linda Lee, Wael Harb, Jordan Berlin, Yan Xing, Paul Swiecicki, Lakshminarayanan Nandagopal, Cong Xu, Yuan Meng, Yonggang Zhao, Zhengyi Wang, Joan Huaqiong Shen

Format: Article
Diterbitkan: BMJ Publishing Group 2020-11-01

Deskripsi

No description available for this item.